Key result
Bedside 0/2-hour POC hs-cTnI pathway linked to ~65-minute reduction in ED length of stay.
Why the study?
Turnaround time in laboratory-based hs-cTn strategies limits rapid ACS rule-out, and the system-level impact of implementing bedside point-of-care hs-cTn testing had not been robustly evaluated using time-series methodology.
Does implementing a bedside 0/2-hour point-of-care high-sensitivity troponin I pathway reduce emergency department length of stay and 4-hour breach rates compared to a laboratory-based 0/3-hour pathway in adult emergency department patients undergoing troponin testing?
Observational (n=2,769)
No
Does implementing a bedside 0/2-hour point-of-care high-sensitivity troponin I pathway reduce emergency department length of stay and 4-hour breach rates compared to a laboratory-based 0/3-hour pathway in adult emergency department patients undergoing troponin testing?
Answers are grounded in this paper and cite their sources.
Implementing bedside point-of-care 0/2-hour high-sensitivity troponin testing significantly reduced emergency department length of stay and 4-hour breach rates, particularly in patients requiring serial testing.
Background High-sensitivity cardiac troponin (hs-cTn) accelerated diagnostic pathways are central to acute coronary syndrome assessment. However, many centres continue laboratory-based strategies where turnaround time limits effective delivery of rapid rule-out algorithms. The system-level impact of implementing bedside point-of-care (POC) hs-cTn testing has not been robustly evaluated using time-series methodology. Purpose To evaluate the real-world operational impact of implementing a 0/2-hour POC hs-cTnI pathway in a high-volume tertiary emergency department (ED) using interrupted time series (ITS) and winter-matched difference-in-differences (DiD) analyses. Methods A hard-switch implementation of a bedside 0/2-hour high-sensitivity cardiac troponin I point-of-care pathway (i-STAT Alinity) replaced a laboratory-based 0/3-hour pathway (Alinity i). All adult (≥18 years) ED attendances undergoing troponin testing were included. Outcomes were emergency department length of stay (LOS) and 4-hour breach rate. A 75-day pre-implementation period was matched to a 75-day post-implementation period. Daily aggregated segmented regression was used to estimate immediate step and slope changes with Newey–West standard errors. Counterfactual modelling projected continuation of the laboratory 0/3-hour trajectory. Seasonal robustness was assessed using winter-matched DiD analysis. Results During the 75-day window, 2,769 troponin-tested attendances were analysed (mean 36.9/day). Baseline characteristics were comparable. Serial-testing patients demonstrated substantial raw improvement, with median LOS reducing from 466 to 417 minutes and 4-hour breach decreasing from 94.6% to 86.1%. ITS demonstrated significant immediate step reductions in median LOS overall (−65.4 minutes, 95% CI −123.0 to −7.8; p<0.05) and in serial patients (−147.7 minutes, 95% CI −233.5 to −62.0; p<0.001). Parallel reductions occurred in 4-hour breach rate (overall −11.7%; p=0.041; serial −15.2%; p<0.001). No significant slope change was detected, consistent with an immediate structural effect attributable to bedside availability of hs-cTn results following POC implementation. Counterfactual modelling estimated a mean post-implementation LOS gap of 82.3 minutes (95% CI 54.9 to 109.7) overall and 178.0 minutes (127.2 to 228.8) in serial patients. Conclusion Implementation of bedside point-of-care high-sensitivity troponin testing was associated with significant and sustained reductions in ED LOS and 4-hour breach rates, most pronounced among serial-testing patients. Time-series and winter-matched analyses indicate these improvements were not explained by seasonal variation. These findings support POC hs-cTn as a scalable operational intervention to unlock effectiveness of accelerated rule-out pathways in high-pressure emergency care systems.ITS Median Length of Stay OverallWinter Matched DiD for Serial Patients
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2026) conducted an observational in Suspected acute coronary syndrome / Emergency department troponin testing (n=2,769). Bedside 0/2-hour high-sensitivity cardiac troponin I point-of-care pathway (i-STAT Alinity) vs. Laboratory-based 0/3-hour pathway (Alinity i) was evaluated on Emergency department length of stay (LOS) and 4-hour breach rate (Step change −65.4 minutes, 95% CI -123.0 to -7.8, p=<0.05). Implementing a bedside 0/2-hour POC hs-cTnI pathway reduced median ED length of stay overall by 65.4 minutes (95% CI -123.0 to -7.8; p<0.05) and 4-hour breach rates by 11.7% (p=0.041).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: